HomeLatest NewsQuality NewsHHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

HHS Moves to Reduce Administrative Procedural Barriers to OUD Treatment

Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder (OUD), U.S. Department of Health and Human Services (HHS) recently announced. HHS said it will publish updates to its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that expands access to medication-assisted treatment by exempting physicians from certain certification requirements.

The new policy potentially limits physicians to treating no more than 30 patients with buprenorphine for OUD at any single time. The HSS will make exceptions to this limit for hospital-based physicians, such as those working in emergency departments.

For more information on this policy, click here.

Stay Connected

Unified Voice Newsletter

Events This Month

Current Month

November

05nov1:00 pm2:00 pmHealth Literacy: How to Help Patients Make Appropriate Health DecisionsSDAHO Webinar

06nov10:00 am11:00 amChallenges and Winning Practices for Behavioral Health Management (member only)SDAHO Webinar

06nov1:00 pm2:00 pmWhat You May Not Realize about Bereavement Care for Veterans and their FamiliesNHPCO Webinar

06nov2:00 pm3:00 pmWhy Referring Clinicians Hesitate To Consult Palliative Care and What We Should Do DifferentlyWebinar

07nov8:00 am9:00 amMeeting the Need: Learning to Support Families Who Have a Dying Child in Your NeighborhoodWebinar